Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Changes SFDA, May Look At U.S. Supplement Regulation Model – NPA

This article was originally published in The Tan Sheet

Executive Summary

The reorganization of China's State Food and Drug Administration should create a "really good opportunity" for the dietary supplement industry, says Jeff Crowther, director of the Natural Products Association's office in China

You may also be interested in...



U.S. Expects “American Standards” From Food, Drug Pacts With China

Agreements reached Dec. 11 will ensure that Chinese food and drug products imported to the U.S. are produced "in accordance with American standards of quality and safety," according to Health and Human Services Secretary Michael Leavitt

More on NPA/China deal

U.S. Pharmacopeia's joint agreement with the Natural Products Association to test raw dietary ingredients is non-exclusive, USP says July 21. Additionally, ingredient suppliers will not be graded, NPA's Vice President of Scientific and Regulatory Affairs Daniel Fabricant stated during a press briefing. The testing program will focus on ingredients meeting certain specifications, he said. NPA anticipates it will "open doors" on the program in September. NPA also has announced the agreement (1"The Tan Sheet" July 23, 2007, In Brief)....

FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down

FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101476

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel